Viola Sgarminato

Viola Sgarminato

Auto-generated profile, based on publicly available information

Viola Sgarminato

Dipartimento di Ingegneria Meccanica e Aerospaziale (DIMEAS) Politecnico di Torino Turin Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
MÁMaria Isabel Álvarez-Castaño
Maria Isabel Álvarez-Castaño
AMAndreas Gejl Madsen
Andreas Gejl Madsen
JMJorge Madrid-Wolff
Jorge Madrid-Wolff
VSViola Sgarminato
Viola Sgarminato
ABAntoine Boniface
Antoine Boniface
CMChristophe Moser
Christophe Moser
Several 3D light-based printing technologies have been developed that rely on the photopolymerization of liquid resins. A recent method, so-called Tomographic Volumetric Additive Manufacturing, allows the fabrication of microscale objects within tens of seconds without the need for support structures. This method works by projecting intensity patterns, computed via a reverse tomography algorithm, into a photocurable resin from different angles to produce a desired 3D shape when the resin reaches the polymerization threshold. Printing using incoherent light patterning has been previously demonstrated. In this work, we show that a light engine with holographic phase modulation unlocks new potential for volumetric printing. The light projection efficiency is improved by at least a factor 20 over amplitude coding with diffraction-limited resolution and its flexibility allows precise light control across the entire printing volume. We show that computer-generated holograms implemented with tiled holograms and point-spread-function shaping mitigates the speckle noise which enables the fabrication of millimetric 3D objects exhibiting negative features of 31 μm in less than a minute with a 40 mW light source in acrylates and scattering materials, such as soft cell-laden hydrogels, with a concentration of 0.5 million cells per mL.

30 August 2024 in Biofabrication
Verified
Journal Article
Open access
VSViola Sgarminato
Viola Sgarminato
JMJorge Madrid-Wolff
Jorge Madrid-Wolff
ABAntoine Boniface
Antoine Boniface
Gianluca CiardelliGianluca Ciardelli
Gianluca Ciardelli
CTChiara Tonda-Turo
Chiara Tonda-Turo
CMChristophe Moser
Christophe Moser
Pancreatic ductal adenocarcinoma (PDAC) is the most common type of pancreatic cancer, a leading cause of cancer-related deaths globally. Initial lesions of PDAC develop within the exocrine pancreas’ functional units, with tumor progression driven by interactions between PDAC and stromal cells. Effective therapies require anatomically and functionally relevant in vitro human models of the pancreatic cancer microenvironment. We employed tomographic volumetric bioprinting, a novel biofabrication method, to create human fibroblast-laden constructs mimicking the tubuloacinar structures of the exocrine pancreas. Human pancreatic ductal epithelial (HPDE) cells overexpressing the KRAS oncogene (HPDE-KRAS) were seeded in the multiacinar cavity to replicate pathological tissue. HPDE cell growth and organization within the structure were assessed, demonstrating the formation of a thin epithelium covering the acini inner surfaces. Immunofluorescence assays showed significantly higher alpha smooth muscle actin (α-SMA) vs. F-actin expression in fibroblasts co-cultured with cancerous versus wild-type HPDE cells. Additionally, α-SMA expression increased over time and was higher in fibroblasts closer to HPDE cells. Elevated interleukin (IL)-6 levels were quantified in supernatants from co-cultures of stromal and HPDE-KRAS cells. These findings align with inflamed tumor-associated myofibroblast behavior, serving as relevant biomarkers to monitor early disease progression and target drug efficacy. To our knowledge, this is the first demonstration of a 3D bioprinted model of exocrine pancreas that recapitulates its true 3-dimensional microanatomy and shows tumor triggered inflammation.

8 June 2026 in Nature Communications
Verified
Journal Article
Open access
FWFelix Wechsler
Felix Wechsler
VSViola Sgarminato
Viola Sgarminato
RRRiccardo Rizzo
Riccardo Rizzo
BNBaptiste Nicolet
Baptiste Nicolet
WJWenzel Jakob
Wenzel Jakob
CMChristophe Moser
Christophe Moser
Tomographic Volumetric Additive Manufacturing (TVAM) is a light-based 3D printing technique capable of producing centimeter-scale objects within seconds. A key challenge lies in the calculation of tomographic projection patterns under non-standard conditions, such as the presence of occlusions and materials with diverse optical properties, including varying refractive indices or scattering surfaces.This work demonstrates a broad range of overprinting scenarios, where new structures are directly printed onto or around pre-existing components made from different materials. Our simulations and experimental verifications perform overprinting of absorbing, refracting, reflecting and scattering elements in both round and square vials.All scenarios are optimized with our differentiable, physically based ray-optics approach using the open-source Dr.TVAM framework, delivering high-quality projections for both laser- and LED-based illuminations within minutes and lower-quality projections within seconds, exceeding existing open-source solutions in speed, flexibility, and quality.

28 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RRRiccardo Rizzo
Riccardo Rizzo
VSViola Sgarminato
Viola Sgarminato
FWFelix Wechsler
Felix Wechsler
CMChristophe Moser
Christophe Moser
Text: Organ-on-chip (OoC) platforms are increasingly adopted for predictive in vitro testing. However, most remain limited by soft-lithography–derived 2.5D microfluidic architectures and non-physiological rigid materials, or bioprinting approaches that require complex and failure-prone post-fabrication assembly. Here, we present a versatile approach that integrates tomographic volumetric additive manufacturing (TVAM) directly within preassembled microfluidic chips, enabling rapid, contactless fabrication of freeform 3D OoCs. Leveraging our open-source optical simulation framework, Dr.TVAM, we perform TVAM in custom-designed chips, eliminating post-printing manual assembly steps that commonly lead to leakage, contamination, and poor reproducibility. This strategy, termed TVAM-in-a-chip, supports the generation of diverse 3D channel architectures in multiple biocompatible photoresins spanning a wide range of chemistries and mechanical properties, including cell-laden formulations. We demonstrate multi-channel designs, compatibility with confocal imaging, and dynamic culture of epithelial and endothelial models. Overall, TVAM-in-a-chip overcomes key limitations of current OoC technologies and paves the way for a new generation of scalable, biomimetic 3D platforms for advanced in vitro modeling.

24 January 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
VSViola Sgarminato
Viola Sgarminato
JMJorge Madrid-Wolff
Jorge Madrid-Wolff
ABAntoine Boniface
Antoine Boniface
Gianluca CiardelliGianluca Ciardelli
Gianluca Ciardelli
CTChiara Tonda-Turo
Chiara Tonda-Turo
CMChristophe Moser
Christophe Moser
1. Pancreatic ductal adenocarcinoma (PDAC) is the most frequent type of pancreatic cancer, one of the leading causes of cancer-related deaths worldwide. The first lesions associated with PDAC occur within the functional units of exocrine pancreas. The crosstalk between PDAC cells and stromal cells plays a key role in tumor progression. Thus, i n vitro , fully human models of the pancreatic cancer microenvironment are needed to foster the development of new, more effective therapies. However, it is challenging to make these models anatomically and functionally relevant. Here, we used tomographic volumetric bioprinting, a novel method to fabricate three-dimensional cell-laden constructs, to produce a portion of the complex convoluted exocrine pancreas in vitro . Human fibroblast-laden gelatin methacrylate-based pancreatic models were processed to reassemble the tubuloacinar structures of the exocrine pancreas and, then human pancreatic ductal epithelial (HPDE) cells overexpressing the KRAS oncogene (HPDE-KRAS) were seeded in the acinar lumen to reproduce the pathological exocrine pancreatic tissue. The growth and organization of HPDE cells within the structure was evaluated and the formation of a thin epithelium which covered the acini inner surfaces in a physiological way inside the 3D model was successfully demonstrated. Interestingly, immunofluorescence assays revealed a significantly higher expressions of alpha smooth muscle actin (α-SMA) vs. actin in the fibroblasts co-cultured with cancerous than with wild-type HPDE cells. Moreover, α-SMA expression increased with time, and it was found to be higher in fibroblasts that laid closer to HPDE cells than in those laying deeper into the model. Increased levels of interleukin (IL)-6 were also quantified in supernatants from co-cultures of stromal and HPDE-KRAS cells. These findings correlate with inflamed tumor-associated fibroblast behavior, thus being relevant biomarkers to monitor the early progression of the disease and to target drug efficacy. To our knowledge, this is the first demonstration of a 3D bioprinted portion of pancreas that recapitulates its true 3-dimensional microanatomy, and which shows tumor triggered inflammation.

29 September 2021 in Biomedical Science and Engineering
Verified
Journal Article
Open access
PDF file
VSViola Sgarminato
Viola Sgarminato
CTChiara Tonda-Turo
Chiara Tonda-Turo
Gianluca CiardelliGianluca Ciardelli
Gianluca Ciardelli
This project aims at reproducing the morphology and the composition of the pancreatic acino-ductal unit. More specifically, this work involves the use of additive manufacturing technologies to fabricate a 3D exocrine glandular tissue model that mimics in vitro the physiological structure experienced by cells in vivo.